NasdaqCM - Nasdaq Real Time Price USD

Ekso Bionics Holdings, Inc. (EKSO)

1.2500

-0.0300

(-2.34%)

At close: April 26 at 4:00 PM EDT

1.2900

+0.04

(+3.20%)

After hours: April 26 at 5:25 PM EDT

Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024

SAN RAFAEL, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the first quarter 2024 after the close of trading on Monday, April 29, 2024. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments. A live webca

GlobeNewswire 5 days ago

EKSO
-2.34%
Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal

SAN RAFAEL, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today announced that the Pricing, Data Analysis, and Coding (“PDAC”) contractor for the Centers for Medicare & Medicaid Services (“CMS”) has determined a final payment level of $91,031.93 for Medicare reimbursement of the Ekso Indego Personal, which took effect on April 1, 2024. As previou

GlobeNewswire 15 days ago

EKSO
-2.34%
Ekso Bionics Holdings Full Year 2023 Earnings: EPS Misses Expectations

Ekso Bionics Holdings ( NASDAQ:EKSO ) Full Year 2023 Results Key Financial Results Revenue: US$18.3m (up 42% from FY...

Simply Wall St. last month

EKSO
-2.34%
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q4 2023 Earnings Call Transcript

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q4 2023 Earnings Call Transcript March 4, 2024 Ekso Bionics Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.22 EPS, expectations were $-0.11. EKSO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and […]

Insider Monkey last month

EKSO
-2.34%
Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates

Ekso Bionics (EKSO) delivered earnings and revenue surprises of -100% and 0.98%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks last month

EKSO
-2.34%
AXGN
Ekso Bionics Reports Record Annual Revenue of $18.3 Million

Sold Record Number of Annual EksoHealth Units in 2023 SAN RAFAEL, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and twelve months ended December 31, 2023. Recent Highlights and Accomplishments Achieved record revenue of $18.3 million for the 2023 full year, an increase of 42% year-over-yearSold a total of 151 EksoHeal

GlobeNewswire last month

EKSO
-2.34%
Ekso Bionics to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024

SAN RAFAEL, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the fourth quarter and full year 2023 after the close of trading on Monday, March 4, 2024. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.

GlobeNewswire last month

EKSO
-2.34%
Best Momentum Stocks to Buy for January 31st

ADMA, EKSO and IKT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 31, 2024.

Zacks 2 months ago

ADMA

EKSO
-2.34%
New Strong Buy Stocks for January 31st

ADMA, IKT, YPF, AVXL and EKSO have been added to the Zacks Rank #1 (Strong Buy) List on January 31, 2024.

Zacks 2 months ago

ADMA

EKSO
-2.34%
When Will Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Become Profitable?

With the business potentially at an important milestone, we thought we'd take a closer look at Ekso Bionics Holdings...

Simply Wall St. 3 months ago

EKSO
-2.34%
Ekso Bionics Announces $4.6 Million Registered Direct Offering

SAN RAFAEL, Calif., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it has entered into a securities purchase agreement with certain institutional investors for the purchase and sale of 2,967,742 shares of common stock at a purchase price of $1.55 per share pursuant to a registered direct offering, resulting in total gross proceeds of approximately $4.6

GlobeNewswire 3 months ago

EKSO
-2.34%
Ekso Bionics Launches GaitCoach Software for EksoNR

SAN RAFAEL, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced the launch of GaitCoach™, its next generation gait therapy software for EksoNR. GaitCoach is a comprehensive gait therapy software that supports a broad spectrum of patients who use EksoNR. This new software simplifies the use of robotics with the intention of improving user trust in technolo

GlobeNewswire 3 months ago

EKSO
-2.34%
Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial Results

SAN RAFAEL, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced preliminary top line financial results for the fourth quarter and fiscal year ended December 31, 2023. Total revenue for the fourth quarter of 2023 is estimated to be in the range of $4.7 million to $4.9 million, compared to total revenue of $3.6 million in the fourth quarter of 2022. Total r

GlobeNewswire 3 months ago

EKSO
-2.34%
Ekso Bionics Receives CMS Coding Approval for Ekso Indego Personal

SAN RAFAEL, Calif., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that the Pricing, Data Analysis, and Coding (“PDAC”) contractor for the Centers for Medicare & Medicaid Services (“CMS”) has completed its review of the Ekso Indego Personal and approved use of Healthcare Common Procedure Coding System (“HCPCS”) Code K1007 to bill Medicare for such device. CM

GlobeNewswire 4 months ago

EKSO
-2.34%
Ekso Bionics to Participate at Centers for Medicare & Medicaid Services (CMS) Second Biannual 2023 Healthcare Common Procedure Coding System (HCPCS) Public Meeting on Wednesday, November 29

SAN RAFAEL, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that the Company will participate at the Centers for Medicare & Medicaid Services’ (“CMS”) Healthcare Common Procedure Coding System (“HCPCS”) public meeting on November 29, 2023, to discuss appropriate Medicare payment for the Ekso Indego Personal. “We appreciate CMS for providing Ekso with

GlobeNewswire 5 months ago

EKSO
-2.34%
Centers for Medicare & Medicaid Services (CMS) Codifies Medicare Coverage for Ekso Indego Personal

Ruling Could Significantly Expand Use of Ekso Indego Personal in Home and Community Markets SAN RAFAEL, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, announces that the Centers for Medicare & Medicaid Services (“CMS”) finalized its Calendar Year 2024 Home Health Prospective Payment System Rule CMS-1780 (“2024 Home Health Rule”), which includes exoskeletons in the M

GlobeNewswire 5 months ago

EKSO
-2.34%
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q3 2023 Earnings Call Transcript

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q3 2023 Earnings Call Transcript October 26, 2023 Ekso Bionics Holdings, Inc. beats earnings expectations. Reported EPS is $-0.24, expectations were $-0.31. Operator: Greetings, and welcome to the Ekso Bionics Quarter Three 2023 Financial Results Call. At this time all participants are in a listen-only mode. A brief question-and-answer session […]

Insider Monkey 5 months ago

EKSO
-2.34%
Q3 2023 Ekso Bionics Holdings Inc Earnings Call

Q3 2023 Ekso Bionics Holdings Inc Earnings Call

Thomson Reuters StreetEvents 5 months ago

EKSO
-2.34%
Ekso Bionics Reports Third Quarter 2023 Revenue Growth of 38%

Achieves Record Quarter of EVO Unit SalesSAN RAFAEL, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and nine months ended September 30, 2023. Recent Highlights and Accomplishments Reported revenue of $4.6 million in the third quarter of 2023, an increase of 38% year-over-yearSold a total of 41 EksoHealth devices in the

GlobeNewswire 5 months ago

EKSO
-2.34%
Ekso Bionics to Report Third Quarter 2023 Financial Results on October 26, 2023

SAN RAFAEL, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the third quarter 2023 after the close of trading on Thursday, October 26, 2023. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments. A live we

GlobeNewswire 6 months ago

EKSO
-2.34%

Performance Overview

Return	EKSO	S&P 500
YTD	-50.00%	+6.92%
1-Year	-19.87%	+25.26%
3-Year	-78.07%	+22.00%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Ekso Bionics Holdings, Inc. (EKSO)

Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024

Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal

Ekso Bionics Holdings Full Year 2023 Earnings: EPS Misses Expectations

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q4 2023 Earnings Call Transcript

Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates

Ekso Bionics Reports Record Annual Revenue of $18.3 Million

Ekso Bionics to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024

Best Momentum Stocks to Buy for January 31st

New Strong Buy Stocks for January 31st

When Will Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Become Profitable?

Ekso Bionics Announces $4.6 Million Registered Direct Offering

Ekso Bionics Launches GaitCoach Software for EksoNR

Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial Results

Ekso Bionics Receives CMS Coding Approval for Ekso Indego Personal

Ekso Bionics to Participate at Centers for Medicare & Medicaid Services (CMS) Second Biannual 2023 Healthcare Common Procedure Coding System (HCPCS) Public Meeting on Wednesday, November 29

Centers for Medicare & Medicaid Services (CMS) Codifies Medicare Coverage for Ekso Indego Personal

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q3 2023 Earnings Call Transcript

Q3 2023 Ekso Bionics Holdings Inc Earnings Call

Ekso Bionics Reports Third Quarter 2023 Revenue Growth of 38%

Ekso Bionics to Report Third Quarter 2023 Financial Results on October 26, 2023

Performance Overview